Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Ormat Technologies Inc is an utilities-renewable business based in the US. Ormat Technologies shares (ORA) are listed on the NYSE and all prices are listed in US Dollars. Ormat Technologies employs 1,402 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$72.14|
|52-week range||$63.48 - $128.22|
|50-day moving average||$69.48|
|200-day moving average||$70.10|
|Wall St. target price||$79.17|
|Dividend yield||$0.47 (0.66%)|
|Earnings per share (TTM)||$1.19|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||5.24%|
|1 month (2021-09-17)||5.42%|
|3 months (2021-07-19)||9.75%|
|6 months (2021-04-19)||-3.84%|
|1 year (2020-10-19)||-1.22%|
|2 years (2019-10-18)||-4.66%|
|3 years (2018-10-19)||39.70%|
|5 years (2016-10-19)||50.98%|
Valuing Ormat Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ormat Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ormat Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 53x. In other words, Ormat Technologies shares trade at around 53x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Ormat Technologies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9478. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ormat Technologies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ormat Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $341.7 million.
The EBITDA is a measure of a Ormat Technologies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$651.6 million|
|Operating margin TTM||26.22%|
|Gross profit TTM||$276.3 million|
|Return on assets TTM||2.95%|
|Return on equity TTM||397.49%|
|Market capitalisation||$4 billion|
TTM: trailing 12 months
There are currently 3.8 million Ormat Technologies shares held short by investors – that's known as Ormat Technologies's "short interest". This figure is 13.8% down from 4.5 million last month.
There are a few different ways that this level of interest in shorting Ormat Technologies shares can be evaluated.
Ormat Technologies's "short interest ratio" (SIR) is the quantity of Ormat Technologies shares currently shorted divided by the average quantity of Ormat Technologies shares traded daily (recently around 293876.33996937). Ormat Technologies's SIR currently stands at 13.06. In other words for every 100,000 Ormat Technologies shares traded daily on the market, roughly 13060 shares are currently held short.
However Ormat Technologies's short interest can also be evaluated against the total number of Ormat Technologies shares, or, against the total number of tradable Ormat Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ormat Technologies's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Ormat Technologies shares in existence, roughly 70 shares are currently held short) or 0.0854% of the tradable shares (for every 100,000 tradable Ormat Technologies shares, roughly 85 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Ormat Technologies.
Find out more about how you can short Ormat Technologies stock.
Dividend payout ratio: 34.81% of net profits
Recently Ormat Technologies has paid out, on average, around 34.81% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.67% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ormat Technologies shareholders could enjoy a 0.67% return on their shares, in the form of dividend payments. In Ormat Technologies's case, that would currently equate to about $0.47 per share.
While Ormat Technologies's payout ratio might seem fairly standard, it's worth remembering that Ormat Technologies may be investing much of the rest of its net profits in future growth.
Ormat Technologies's most recent dividend payout was on 31 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 16 August 2021 (the "ex-dividend date").
Over the last 12 months, Ormat Technologies's shares have ranged in value from as little as $63.4794 up to $128.2238. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ormat Technologies's is 0.3487. This would suggest that Ormat Technologies's shares are less volatile than average (for this exchange).
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guadeloupe, Guatemala, Ethiopia, New Zealand, Honduras, and internationally. The company operates through three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal, recovered energy-based electricity generation, and remote power units, such as fossil fuel powered turbo-generators and heavy duty direct-current generators. This segment also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. The Product segment serves contractors; developers, owners, and operators of geothermal power plants; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.